Bioimpedance Analyzers Market

Bioimpedance Analyzers Market by Type (Single-frequency, Multiple-frequency, Dual-frequency) Modality (Wired, Wireless) Application (Segmental Body Measurement, Whole Body Measurement) End User (Hospitals, Home Users) - Analysis & Global Forecasts to 2026

Report Code: MD 7973 Sep, 2021, by marketsandmarkets.com

[173 Pages Report] The global bioimpedance analyzers market size is projected to reach USD 767 million by 2026 from USD 429 million in 2021, at a CAGR of 10.2% during the forecast period. Growth of the market is driven mainly by the growing prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers.

Bioimpedance Analyzers Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID -19 IMPACT ON THE BIOIMPEDANCE ANALYZERS MARKET

The COVID-19 pandemic is expected to have a positive impact on the bioimpedance analyzers market. The WHO has confirmed that more than 95% of the deaths in Europe occurred in patients older than 60 years, and more than 50% of all global fatalities involved people aged 80 years or older. WHO studies further reported that eight in ten deaths occurred in individuals with at least one comorbidity, such as CVD, hypertension, and diabetes.

COVID-19 causes a breakdown of muscle mass and a decreased appetite. This leads to malnutrition and significant loss of muscle mass. This is an important consideration for obese people, as they already have very low muscle mass. The European Society for Clinical Nutrition and Metabolism (ESPEN) gives practical guidance for the nutritional management of COVID-19 patients, emphasizing the importance of muscle mass. Thus, assessing body composition and muscle mass during hospitalization and also afterward is extremely important to protect patients as well as manage and monitor their improvement.

Global Bioimpedance Analyzers Market Dynamics

DRIVER: Increasing prevalence of lifestyle diseases

Unhealthy lifestyles, such as sedentary work environments, consumption of junk food, and increased mobility automation have increased the prevalence of various lifestyle diseases, such as obesity, high blood pressure, and diabetes.

According to the CDC, the global prevalence of obesity increased to 42.4% in 2019 from 30.5% in 2000. Obesity is now termed a worldwide epidemic; approximately 57.8% of all adults are expected to be classified as obese by 2030 (Source: WHO, 2020). In addition to developed countries, obesity is now an epidemic in low- and middle-income countries as well. As of 2019, in Africa, the prevalence of childhood obesity has increased by approximately 24% since 2000. Bioimpedance analyzers offer an accurate measurement of the amount of fat, muscle, and bone in the human body. This will fueling the growth of the bioimpedance analyzers market.

OPPORTUNITY: Emerging market across the Asia Pacific and Latin America

Emerging economies such as India, China, and Brazil are expected to witness high growth in the bioimpedance analyzers market. This can be attributed to the increasing prevalence of lifestyle diseases, growing awareness about health and obesity, and infrastructural improvements in these countries. China is a prominent market in this regard, given its recent infrastructural improvements, rapid economic growth, rising domestic demand, and public-private initiatives to support healthcare research. China’s State Council approved the 2016–2020 National Fitness Plan, which has motivated all national fitness levels and increased sports participation.

CHALLENGE: Inconsistency in the accuracy of different bioimpedance analyzers

Although the technology is improving, it is difficult to obtain accurate body fat measurements from most commercially available body fat analyzers. The working of analyzers includes passing an electrical current that follows the path of least resistance through the body. As fat contains less water, the fat-free mass has less resistance to electrical current. However, a large amount of fat underneath the skin is not detected by these analyzers. In addition, body impedance varies among different ethnic groups and influences the accuracy of body composition analyzers.

The multi-frequency bioimpedance analyzers segment is expected to grow at the highest CAGR during the forecast period

Based on the product, the bioimpedance analyzers market is segmented into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. The consumables segment is projected to witness the highest growth during the forecast period. The preference for multi-frequency bioimpedance analyzers is high among end users as they can be used for both segmental and whole-body measurement, unlike single-frequency bioimpedance analyzers.

The application segment accounted for the largest share of the bioimpedance analyzers market in 2020

By application, the bioimpedance analyzers market is a segmented segmental body measurement and whole body measurement. The segmental body measurement segment accounted for the largest market share in 2020. The large share of this segment can be attributed to the increasing prevalence of obesity and metabolic disorders.

Fitness club and wellness centers for the largest share of the bioimpedance analyzers market in 2020

Based on end-users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs and wellness centers, home users, and other end users The fitness clubs and wellness centers segment accounted for the largest share of the bioimpedance analyzers market in 2020. The increasing number of fitness clubs and wellness centers and the growing awareness about health and fitness across the globe are the major driving factor for this market.

North America accounted for the largest share of the bioimpedance analyzers market in 2020

Based on the region, the bioimpedance analyzers market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the bioimpedance analyzers market. The large share of North America can be attributed to factors such as the growing obesity rate, government initiatives to encourage healthy lifestyles, increasing use of body composition analyzers for assessing athlete fitness, and increasing number of health clubs and fitness centers.

Bioimpedance Analyzers Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Some of the major players operating in this market are Tanita Corporation (Japan), Omron Corporation (Japan). In 2020, Tanita Corporation (Japan) held the leading position in the market. The company has a strong geographic presence across North America, Europe, and Asia Pacific. Omron Corporation (Japan) held the second position in the bioimpedance analyzers market in 2020.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2019–2026

Base Year Considered

2020

Forecast Period

2021–2026

Forecast Units

Value (USD Million)

Segments Covered

Products, Modality, Application, End User and Region

Geographies Covered

North America (US, Canada), Europe (Germany, France, UK, and RoE), APAC (China, India, Japan, and the RoAPAC), and Rest of the World

Companies Covered

Omron Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), seca GmbH & Co. KG (Germany), EVOLT 360 (Australia), SELVAS Healthcare (South Korea), Charder Electronic Co. Ltd. (China), Fook Tin Group Holding Ltd. (China), Bodystat Ltd. (UK), Maltron International (UK), Biotekna (Italy), Withings (France), Biodynamics Corporation (US), Akern (Italy), Xiaomi (China), Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd. (China), Lumsail Industrial Inc. (China), Guangzhou Beautylife Electronic Technology Co., Ltd. (China), and Bioparhom (France)

This research report categorizes the bioimpedance analyzers market into the following segments and subsegments:

Product

  • Multi-frequency Analyzers
  • Single-frequency Analyzers
  • Dual-frequency Analyzers

Modality

  • Wired Bioimpedance Analyzers
  • Wireless Bioimpedance Analyzers

Application

  • Whole-body Measurement
  • Segmental Body Measurement

End User

  • Fitness Clubs and Wellness Centers
  • Home Users
  • Hospitals
  • Other End User

Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • RoE 3
  • Asia Pacific
    • China
    • Japan
    • Taiwan
    • Australia
    • RoAPAC
  • Rest of the World

Recent Developments:

  • In 2020, Inbody launched the ThInBody 970 at CES Las Vegas
  • In 2017, Selvas Healthcare launched the ACCUNIQ BC380 artificial intelligence-based body composition analyzer globally.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           FIGURE 5 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 COVID-19 SPECIFIC ASSUMPTIONS
    2.7 RISK ASSESSMENT/FACTOR ANALYSIS
           TABLE 1 RISK ASSESSMENT/FACTOR ANALYSIS
    2.8 COVID-19 HEALTH ASSESSMENT
    2.9 COVID-19 ECONOMIC ASSESSMENT
    2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO

3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 9 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    FIGURE 10 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021 VS. 2026 (USD MILLION)
    FIGURE 11 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 BIOIMPEDANCE ANALYZERS MARKET OVERVIEW
           FIGURE 14 INCREASING INCIDENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
    4.2 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION
           FIGURE 15 SEGMENTAL BODY MEASUREMENT SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
    4.3 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT AND COUNTRY, 2020
           FIGURE 16 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS DOMINATED THE NORTH AMERICAN MARKET IN 2020
    4.4 GEOGRAPHICAL SNAPSHOT OF THE BIOIMPEDANCE ANALYZERS MARKET
           FIGURE 17 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 51)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 18 BIOIMPEDANCE ANALYZERS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing prevalence of lifestyle diseases
                    5.2.1.2 Initiatives by governments and private organizations to promote healthy lifestyles
                    5.2.1.3 Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers
           5.2.2 OPPORTUNITIES
                    5.2.2.1 Emerging markets across the Asia Pacific and Latin America
           5.2.3 CHALLENGES
                    5.2.3.1 Inconsistency in the accuracy of different bioimpedance analyzers
    5.3 COVID-19 IMPACT ANALYSIS
    5.4 RANGES/SCENARIOS
           5.4.1 BIOIMPEDANCE ANALYZERS MARKET
                    FIGURE 19 PESSIMISTIC SCENARIO
                    FIGURE 20 OPTIMISTIC SCENARIO
                    FIGURE 21 REALISTIC SCENARIO
    5.5 VALUE CHAIN ANALYSIS
           FIGURE 22 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES
    5.6 SUPPLY CHAIN ANALYSIS
           FIGURE 23 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.7 PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 INTENSITY OF COMPETITIVE RIVALRY
           5.7.3 BARGAINING POWER OF BUYERS
           5.7.4 BARGAINING POWER OF SUPPLIERS
           5.7.5 THREAT OF SUBSTITUTES
    5.8 TECHNOLOGY ANALYSIS
    5.9 REGULATORY LANDSCAPE
           FIGURE 24 510(K) APPROVAL PROCESS
    5.10 PATENT ANALYSIS
    5.11 TRADE ANALYSIS
           5.11.1 TRADE ANALYSIS FOR BIOIMPEDANCE ANALYZERS
                    TABLE 2 IMPORT DATA FOR BIOIMPEDANCE ANALYZERS, BY COUNTRY, 2016–2020 (USD MILLION)
                    TABLE 3 EXPORT DATA FOR BIOIMPEDANCE ANALYZERS, BY COUNTRY, 2016–2020 (USD MILLION)
    5.12 PRICING ANALYSIS
                    TABLE 4 PRICE RANGE FOR BIOIMPEDANCE ANALYZERS
    5.13 ECOSYSTEM ANALYSIS
           5.13.1 ROLE IN ECOSYSTEM
                    FIGURE 25 KEY PLAYERS IN THE BIOIMPEDANCE ANALYZERS ECOSYSTEM
    5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS
           5.14.2 REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS

6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT (Page No. - 64)
    6.1 INTRODUCTION
           TABLE 5 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
           TABLE 6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
    6.2 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS
           6.2.1 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS SEGMENT DOMINATED THE MARKET IN 2020
                    TABLE 7 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 8 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
    6.3 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS
           6.3.1 INCREASING OBESE POPULATION TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
                    TABLE 9 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 10 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
    6.4 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS
           6.4.1 INCREASING PREVALENCE OF CHRONIC DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
                    TABLE 11 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 12 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)

7 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY (Page No. - 69)
    7.1 INTRODUCTION
           TABLE 13 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
           TABLE 14 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
    7.2 WIRELESS BIOIMPEDANCE ANALYZERS
           7.2.1 WIRELESS BIOIMPEDANCE ANALYZERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
                    TABLE 15 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 16 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
    7.3 WIRED BIOIMPEDANCE ANALYZERS
           7.3.1 BENEFITS OF WIRED DEVICES TO DRIVE THEIR DEMAND AMONG END USERS
                    TABLE 17 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 18 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)

8 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION (Page No. - 73)
    8.1 INTRODUCTION
           TABLE 19 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
           TABLE 20 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
    8.2 SEGMENTAL BODY MEASUREMENT
           8.2.1 SEGMENTAL BODY MEASUREMENT SEGMENT TO DOMINATE THE BIOIMPEDANCE ANALYZERS MARKET DURING THE FORECAST PERIOD
                    TABLE 21 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 22 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2020–2026 (USD MILLION)
    8.3 WHOLE-BODY MEASUREMENT
           8.3.1 INCREASING INCIDENCE OF METABOLIC DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
                    TABLE 23 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 24 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2020–2026 (USD MILLION)

9 BIOIMPEDANCE ANALYZERS MARKET, BY END USER (Page No. - 77)
    9.1 INTRODUCTION
           TABLE 25 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
           TABLE 26 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
    9.2 HOSPITALS
           9.2.1 INCREASING AWARENESS OF HEALTH AND FITNESS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                    TABLE 27 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 28 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS, BY REGION, 2020–2026 (USD MILLION)
    9.3 FITNESS CLUBS AND WELLNESS CENTERS
           9.3.1 FITNESS CLUBS AND WELLNESS CENTERS SEGMENT TO DOMINATE THE BIOIMPEDANCE ANALYZERS MARKET
                    FIGURE 26 US: NUMBER OF HEALTH CLUBS, 2012–2019
                    TABLE 29 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 30 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY REGION, 2020–2026 (USD MILLION)
    9.4 HOME USERS
           9.4.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                    TABLE 31 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2017–2019 (USD MILLION)
                    TABLE 32 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2020–2026 (USD MILLION)
    9.5 OTHER END USERS
           TABLE 33 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2017–2019 (USD MILLION)
           TABLE 34 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2020–2026 (USD MILLION)

10 BIOIMPEDANCE ANALYZERS MARKET, BY REGION (Page No. - 84)
     10.1 INTRODUCTION
               TABLE 35 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION)
               TABLE 36 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION)
     10.2 NORTH AMERICA
               FIGURE 27 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
               TABLE 37 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
               TABLE 38 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
               TABLE 39 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
               TABLE 40 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
               TABLE 41 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
               TABLE 42 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
               TABLE 43 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
               TABLE 44 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
               TABLE 45 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
               TABLE 46 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.2.1 US
                       10.2.1.1 Increasing number of health clubs and fitness centers driving market growth in the US
                                   TABLE 47 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                   TABLE 48 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 49 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                   TABLE 50 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                   TABLE 51 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                   TABLE 52 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 53 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                   TABLE 54 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.2.2 CANADA
                       10.2.2.1 High prevalence of obesity in Canada to support market growth
                                   TABLE 55 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                   TABLE 56 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 57 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                   TABLE 58 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                   TABLE 59 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                   TABLE 60 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 61 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                   TABLE 62 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
     10.3 EUROPE
               TABLE 63 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
               TABLE 64 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
               TABLE 65 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
               TABLE 66 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
               TABLE 67 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
               TABLE 68 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
               TABLE 69 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
               TABLE 70 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
               TABLE 71 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
               TABLE 72 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.3.1 GERMANY
                       10.3.1.1 Germany is the largest market for bioimpedance analyzers in Europe
                                   TABLE 73 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                   TABLE 74 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 75 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                   TABLE 76 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                   TABLE 77 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                   TABLE 78 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 79 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                   TABLE 80 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.3.2 UK
                       10.3.2.1 UK is the second-largest market for bioimpedance analyzers in Europe
                                   TABLE 81 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                   TABLE 82 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 83 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                   TABLE 84 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                   TABLE 85 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                   TABLE 86 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 87 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                   TABLE 88 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.3.3 FRANCE
                       10.3.3.1 Increasing obese population and rising prevalence of metabolic disorders to drive market growth in France
                                   TABLE 89 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                   TABLE 90 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 91 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                   TABLE 92 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                   TABLE 93 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                   TABLE 94 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 95 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                   TABLE 96 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.3.4 REST OF EUROPE
                       TABLE 97 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                       TABLE 98 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                       TABLE 99 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                       TABLE 100 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                       TABLE 101 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                       TABLE 102 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                       TABLE 103 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                       TABLE 104 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
     10.4 ASIA PACIFIC
               FIGURE 28 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
               TABLE 105 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017–2019 (USD MILLION)
               TABLE 106 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)
               TABLE 107 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
               TABLE 108 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
               TABLE 109 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
               TABLE 110 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
               TABLE 111 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
               TABLE 112 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
               TABLE 113 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
               TABLE 114 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.4.1 JAPAN
                       10.4.1.1 Strong presence of local players to drive market growth in Japan
                                   TABLE 115 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                   TABLE 116 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 117 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                   TABLE 118 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                   TABLE 119 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                   TABLE 120 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 121 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                   TABLE 122 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.4.2 CHINA
                       10.4.2.1 Increasing obese population to drive market growth in China
                                   TABLE 123 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                   TABLE 124 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 125 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                   TABLE 126 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                   TABLE 127 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                   TABLE 128 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 129 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                   TABLE 130 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.4.3 TAIWAN
                       10.4.3.1 Increasing incidence of lifestyle diseases to drive market growth in Taiwan
                                   TABLE 131 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                   TABLE 132 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 133 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                   TABLE 134 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                   TABLE 135 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                   TABLE 136 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 137 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                   TABLE 138 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.4.4 AUSTRALIA
                       10.4.4.1 Increasing obese population to drive market growth in Australia
                                   TABLE 139 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                                   TABLE 140 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                                   TABLE 141 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                                   TABLE 142 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                                   TABLE 143 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                                   TABLE 144 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                                   TABLE 145 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                                   TABLE 146 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                       TABLE 147 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
                       TABLE 148 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
                       TABLE 149 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
                       TABLE 150 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
                       TABLE 151 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
                       TABLE 152 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
                       TABLE 153 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
                       TABLE 154 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)
     10.5 REST OF THE WORLD
               TABLE 155 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION)
               TABLE 156 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)
               TABLE 157 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION)
               TABLE 158 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION)
               TABLE 159 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION)
               TABLE 160 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION)
               TABLE 161 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION)
               TABLE 162 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 134)
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
               TABLE 163 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE BIOIMPEDANCE ANALYZERS MARKET
     11.3 MARKET SHARE ANALYSIS
               TABLE 164 BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION
     11.4 COMPANY EVALUATION MATRIX
             11.4.1 STARS
             11.4.2 EMERGING LEADERS
             11.4.3 PERVASIVE PLAYERS
             11.4.4 PARTICIPANTS
                       FIGURE 29 COMPANY EVALUATION MATRIX: BIOIMPEDANCE ANALYZERS MARKET
     11.5 COMPANY EVALUATION MATRIX (SMES/START-UPS)
             11.5.1 PROGRESSIVE COMPANIES
             11.5.2 STARTING BLOCKS
             11.5.3 RESPONSIVE COMPANIES
             11.5.4 DYNAMIC COMPANIES
                       FIGURE 30 COMPANY EVALUATION MATRIX: BIOIMPEDANCE ANALYZERS MARKET (SMES & START-UPS)
     11.6 COMPANY FOOTPRINT ANALYSIS
               TABLE 165 OVERALL FOOTPRINT OF COMPANIES IN THE BIOIMPEDANCE ANALYZERS MARKET
               TABLE 166 PRODUCT FOOTPRINT OF COMPANIES
               TABLE 167 REGIONAL FOOTPRINT OF COMPANIES

12 COMPANY PROFILES (Page No. - 143)
     12.1 KEY PLAYERS
(Business Overview, Products/Solutions Offered, Recent Developments, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)*
             12.1.1 OMRON CORPORATION
                       TABLE 168 OMRON CORPORATION: BUSINESS OVERVIEW
                       FIGURE 31 OMRON CORPORATION: COMPANY SNAPSHOT (2020)
             12.1.2 TANITA CORPORATION
                       TABLE 169 TANITA CORPORATION: BUSINESS OVERVIEW
             12.1.3 INBODY CO., LTD.
                       TABLE 170 INBODY CO., LTD.: BUSINESS OVERVIEW
             12.1.4 RJL SYSTEMS, INC.
                       TABLE 171 RJL SYSTEMS, INC.: BUSINESS OVERVIEW
             12.1.5 SECA GMBH & CO. KG
                       TABLE 172 SECA GMBH & CO. KG: BUSINESS OVERVIEW
             12.1.6 EVOLT 360
                       TABLE 173 EVOLT 360: BUSINESS OVERVIEW
             12.1.7 SELVAS HEALTHCARE (FORMERLY KNOWN AS JAWON MEDICAL)
                       TABLE 174 SELVAS HEALTHCARE: BUSINESS OVERVIEW
             12.1.8 FOOK TIN GROUP HOLDINGS LTD.
                       TABLE 175 FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW
             12.1.9 BODYSTAT LTD.
                       TABLE 176 BODYSTAT LTD.: BUSINESS OVERVIEW
             12.1.10 CHARDER ELECTRONIC CO., LTD.
                       TABLE 177 CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
             12.1.11 MALTRON INTERNATIONAL
                       TABLE 178 MALTRON INTERNATIONAL: BUSINESS OVERVIEW
*Business Overview, Products/Solutions Offered, Recent Developments, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.
     12.2 START-UPS/SME PLAYERS
             12.2.1 BIOTEKNA
                       TABLE 179 BIOTEKNA: COMPANY OVERVIEW
             12.2.2 BIODYNAMICS CORPORATION
                       TABLE 180 BIODYNAMICS CORPORATION: COMPANY OVERVIEW
             12.2.3 AKERN
                       TABLE 181 AKERN: COMPANY OVERVIEW
             12.2.4 WITHINGS
                       TABLE 182 WITHINGS: COMPANY OVERVIEW
             12.2.5 XIAOMI
                       TABLE 183 XIAOMI: COMPANY OVERVIEW
             12.2.6 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.
                       TABLE 184 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
             12.2.7 LUMSAIL INDUSTRIAL INC.
                       TABLE 185 LUMSAIL INDUSTRIAL INC.: COMPANY OVERVIEW
             12.2.8 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.
                       TABLE 186 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
             12.2.9 BIOPARHOM
                       TABLE 187 BIOPARHOM: COMPANY OVERVIEW
             12.2.10 MICROLIFE
                       TABLE 188 MICROLIFE: COMPANY OVERVIEW

13 APPENDIX (Page No. - 166)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

The study involved four major activities in estimating the current size of the bioimpedance analyzers market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (hospitals, fitness laboratories and wellness centers, home users) and supply sides (bioimpedance analyzer manufacturers and distributors).

The following is a breakdown of the primary respondents:

Bioimpedance Analyzers Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioimpedance analyzers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioimpedance analyzers industry.

Report Objectives

  • To define, describe, and forecast the global bioimpedance analyzers market based on product, modality, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, new product launches, and partnerships in the bioimpedance analyzers market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
  • Geographic Analysis: Further breakdown of Rest of the World bioimpedance analyzers market into specific countries bioimpedance analyzers market and further breakdown of the European bioimpedance analyzers market into specific countries
COVID-19

Get in-depth analysis of the COVID-19 impact on the Bioimpedance Analyzers Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Bioimpedance Analyzers Market

Request For Special Pricing
Report Code
MD 7973
Published ON
Sep, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Bioimpedance Analyzers Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home